EGFR and metabolic dysfunction-associated steatotic liver disease: As is revealed that NAFLD metabolic microenvironment enriched lipid bioavailability in metastatic CRC cells and promoted metastatic CRC cell stemness via EGFR palmitoylation, we then sought to identify a clinically available therapeutic approach to disturb this process and suppress liver metastasis of CRC in NAFLD.